Literature DB >> 2669371

Bioelectrical impedance in clinical practice.

B J Zarowitz1, A M Pilla.   

Abstract

Bioelectrical impedance (BI) relies on the conduction of a low-voltage alternating current through the body. Lean tissue and fluids containing electrolytes conduct the current and cell membranes serve as capacitors and account for capacitive resistance. Fat and bone are poor conductors. Measurement of the voltage drop of the applied current yields resistance (R) and reactance (Xc). R and Xc are used with height, weight, age, and gender in a number of multiple regression relationships to predict body composition compartments such as fat-free mass, lean body mass, extracellular mass, and body cell mass. The technique has been compared with and validated against traditional measures of body composition analysis. In clinical practice, BI has been used to monitor fluid status in burn and dialysis patients, assess changes of body cell mass with nutritional repletion, and predict pharmacokinetic parameters and dose of theophylline and aminoglycoside antibiotics. BI is a noninvasive, safe, rapid, and reproducible technique with exciting potential in clinical practice.

Entities:  

Mesh:

Year:  1989        PMID: 2669371     DOI: 10.1177/1060028089023007-803

Source DB:  PubMed          Journal:  DICP        ISSN: 1042-9611


  20 in total

Review 1.  Clinical pharmacokinetics 1990.

Authors:  G R Matzke; W L St Peter
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

2.  Bioelectrical impedance phase angle as a prognostic indicator of survival in head-and-neck cancer.

Authors:  M S Władysiuk; R Mlak; K Morshed; W Surtel; A Brzozowska; T Małecka-Massalska
Journal:  Curr Oncol       Date:  2016-10-25       Impact factor: 3.677

3.  A bioimpedance analysis of head-and-neck cancer patients undergoing radiotherapy.

Authors:  K Kohli; R Corns; K Vinnakota; P Steiner; C Elith; D Schellenberg; W Kwan; A Karvat
Journal:  Curr Oncol       Date:  2018-06-28       Impact factor: 3.677

4.  Bioelectrical impedance phase angle and subjective global assessment in detecting malnutrition among newly diagnosed head and neck cancer patients.

Authors:  Teresa Małecka-Massalska; Radoslaw Mlak; Agata Smolen; Kamal Morshed
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-10       Impact factor: 2.503

5.  Individual theophylline dosing based on bioelectrical impedance analysis.

Authors:  J S Sidhu; E J Triggs; B G Charles; B A Smithurst
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

6.  Predictive value of tetrapolar body impedance measurements for hydration status in critically ill patients.

Authors:  A N Roos; R G Westendorp; R Brand; J H Souverijn; M Frölich; A E Meinders
Journal:  Intensive Care Med       Date:  1995-02       Impact factor: 17.440

7.  Bioelectrical impedance analysis in clinical practice: implications for hepatitis C therapy BIA and hepatitis C.

Authors:  Alisan Kahraman; Johannes Hilsenbeck; Monika Nyga; Judith Ertle; Alexander Wree; Mathias Plauth; Guido Gerken; Ali E Canbay
Journal:  Virol J       Date:  2010-08-16       Impact factor: 4.099

8.  Bioimpedance vector pattern in Taiwanese and Polish college students detected by bioelectric impedance vector analysis: preliminary observations.

Authors:  Teresa Malecka-Massalska; Agata Smolen; Elzbieta Madro; Wojciech Surtel
Journal:  ScientificWorldJournal       Date:  2012-04-19

9.  Bioelectrical phase angle values in a clinical sample of ambulatory rehabilitation patients.

Authors:  Simon M Gunn; Julie A Halbert; Lynne C Giles; Jacqueline M Stepien; Michelle D Miller; Maria Crotty
Journal:  Dyn Med       Date:  2008-09-10

10.  Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer.

Authors:  Digant Gupta; Carolyn A Lammersfeld; Pankaj G Vashi; Jessica King; Sadie L Dahlk; James F Grutsch; Christopher G Lis
Journal:  BMC Cancer       Date:  2009-01-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.